Patents by Inventor Mohammed DIBAS

Mohammed DIBAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
    Publication number: 20220288031
    Abstract: Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
    Type: Application
    Filed: October 29, 2021
    Publication date: September 15, 2022
    Inventors: Mohammed Dibas, Daniel W. Gil, Wayne Chen, Miguel Alcantara
  • COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIA
    Publication number: 20220273557
    Abstract: The present invention is related to topical ophthalmic compositions comprising brimonidine. Also described herein are methods for the treatment of ocular conditions (e.g., presbyopia), methods for improving near reading speed in a subject with presbyopia, methods for improving near vision in a subject with presbyopia, and methods for reducing pupil diameter in a subject with presbyopia using the topical ophthalmic compositions.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Inventors: Mohammed Dibas, Daniel Gil, Arthur Bradley, Renfeng Xu
  • COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIA
    Publication number: 20220273605
    Abstract: The present invention is related to topical ophthalmic compositions comprising one or more active components. The active components in the topical ophthalmic compositions include, but are not limited to carbachol, phospholine iodide and pharmaceutically acceptable salts thereof. Also described herein are methods for the treatment of presbyopia, methods for improving near vision in a subject with presbyopia, and methods for reducing pupil diameter in a subject with presbyopia using the topical ophthalmic compositions.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Inventors: Michael R. Robinson, Mohammed Dibas, Anuradha Gore
  • PRESBYOPIA TREATMENTS
    Publication number: 20220241245
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Application
    Filed: January 12, 2022
    Publication date: August 4, 2022
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
    Publication number: 20220160623
    Abstract: Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
    Type: Application
    Filed: June 30, 2021
    Publication date: May 26, 2022
    Inventors: Mohammed Dibas, Daniel W. Gil, Wayne Chen, Miguel Alcantara
  • Presbyopia treatments
    Patent number: 11285134
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: March 29, 2022
    Assignee: ALLERGAN, INC.
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR REDUCING REDNESS AND INCREASING WHITENESS IN EYES AND OTHER OPHTHALMIC PURPOSES
    Publication number: 20210260042
    Abstract: The disclosure provides, inter alia, methods of reducing eye redness and/or increasing eye whiteness using alpha-2-adrenergic receptor agonists.
    Type: Application
    Filed: February 19, 2021
    Publication date: August 26, 2021
    Inventor: Mohammed Dibas
  • PHARMACEUTICAL COMPOSITIONS OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND THEIR USE FOR IMPROVING VISION
    Publication number: 20210260041
    Abstract: Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
    Type: Application
    Filed: February 19, 2021
    Publication date: August 26, 2021
    Inventors: Richard Graham, Ke Wu, Massoud Fahid, Mohammed Dibas
  • Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia
    Patent number: 11077053
    Abstract: Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: August 3, 2021
    Assignee: ALLERGAN, INC.
    Inventors: Mohammed Dibas, Daniel W. Gil, Wayne Chen, Miguel Alcantara
  • THE USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
    Publication number: 20210205273
    Abstract: Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
    Type: Application
    Filed: August 20, 2019
    Publication date: July 8, 2021
    Inventors: Mohammed Dibas, Daniel W. Gil, Wayne Chen, Miguel Alcantara
  • USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
    Publication number: 20210059930
    Abstract: Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 4, 2021
    Inventors: Mohammed Dibas, Daniel W. Gil, Wayne Chen, Miguel Alcantara
  • PRESBYOPIA TREATMENTS
    Publication number: 20210008034
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Application
    Filed: February 14, 2020
    Publication date: January 14, 2021
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • Presbyopia treatments
    Patent number: 10610518
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: April 7, 2020
    Assignee: ALLERGAN, INC.
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • PRESBYOPIA TREATMENTS
    Publication number: 20190321337
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Application
    Filed: April 24, 2019
    Publication date: October 24, 2019
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • METHODS, COMPOSITIONS, AND COMPOUNDS FOR TREATMENT OF DERMATOLOGICAL AND OCULAR CONDITIONS
    Publication number: 20190275022
    Abstract: Described herein are methods, compositions, and compounds for the treatment of dermatological and ocular conditions.
    Type: Application
    Filed: July 19, 2017
    Publication date: September 12, 2019
    Inventors: Mohammed DIBAS, John DONELLO